keyword
MENU ▼
Read by QxMD icon Read
search

hairloss

keyword
https://www.readbyqxmd.com/read/27282434/how-to-reach-emotions-with-psychosomatic-patients-a-case-report
#1
Gwenaëlle Colaianni, Francoise Poot
Alopecia areata (patchy hairloss) often indicates to the dermatologist the existence of psychological disorders, mostly anxiety and depression. Psychosomatic conditions are usually associated with difficulty in expressing emotions, as is the case in alexithymia, and this difficulty is often seen in patients with alopecia areata. This case study aims to show how to help these patients connect with their emotions and how the somatic symptom can become meaningful by using a unifying approach, which challenges the beliefs, the rules and the interactions of both the individual and the family, as well as the emotions expressed or suppressed...
August 23, 2016: Acta Dermato-venereologica
https://www.readbyqxmd.com/read/24770522/case-for-diagnosis-alopecia-areata-and-congenital-triangular-alopecia
#2
Lorena Cassia de Carvalho Oliveira, Amanda Rodrigues Miranda, Sebastião Alves Pinto, Mayra Ianhez
A 6 year-old patient began to experience localized hairloss in the right temporal region three years ago. During the first appointment, diagnoses of alopecia areata and congenital triangular alopecia were made. After one year, there was no change. Upon dermatological examination, non-scarring alopecia was noted in the right temporal region, revealing extremely fine and fair hair follicles. A dermoscopy revealed only thin vellus-type hairs. Congenital triangular alopecia is a condition commonly confused with alopecia areata and is thus underdiagnosed...
March 2014: Anais Brasileiros de Dermatologia
https://www.readbyqxmd.com/read/23130269/finasteride-and-sexual-side-effects
#3
Venkataram Mysore
Finasteride, a 5-alpha reductase inhibitor, widely used in the medical management of male pattern hairloss, has been reported to cause sexual side effects. This article critically examines the evidence available and makes recommendations as to how a physician should counsel a patient while prescribing the drug.
January 2012: Indian Dermatology Online Journal
https://www.readbyqxmd.com/read/21985533/comparison-of-two-shampoos-for-the-treatment-of-canine-malassezia-dermatitis-a-randomised-controlled-trial
#4
RANDOMIZED CONTROLLED TRIAL
L Maynard, C A Rème, S Viaud
OBJECTIVES: Two antimicrobial shampoos for treatment of canine Malassezia dermatitis (CMD) were compared in a prospective, randomised, single-blinded, field clinical trial. METHODS: Sixty-seven dogs with pedal or generalised dermatitis associated with Malassezia overgrowth (MO) were treated with 3% chlorhexidine shampoo (3%CHX) or 2% miconazole-2% chlorhexidine shampoo (2%MIC/CHX) and evaluated for up to 6 weeks until cytological recovery. Pruritus, erythema, papules, greasy seborrhoea, scaling, malodour, excoriations, secondary hairloss, lichenification, hyperpigmentation and lesion extent were each scored on a 0-3 severity scale and combined making an aggregate score...
November 2011: Journal of Small Animal Practice
https://www.readbyqxmd.com/read/21188025/mesotherapy-in-management-of-hairloss-is-it-of-any-use
#5
Venkataram Mysore
Mesotherapy has received a lot of publicity in the media and internet about its possible role in androgenetic alopecia. However, the subject is controversial in view of lack of documented evidence. This article provides a critical commentary on the use of mesotherapy in the management of androgenetic alopecia.
January 2010: International Journal of Trichology
https://www.readbyqxmd.com/read/20273746/treatment-of-hairloss-with-estrogen
#6
M A GOLDZIEHER
No abstract text is available yet for this article.
1946: Dermatologica
https://www.readbyqxmd.com/read/14341477/-baldness-and-hairloss
#7
J W MALI
No abstract text is available yet for this article.
May 29, 1965: Nederlands Tijdschrift Voor Geneeskunde
https://www.readbyqxmd.com/read/11016856/therapeutic-interventions-in-mice-with-chronic-proliferative-dermatitis-cpdm-cpdm
#8
M J Gijbels, G R Elliott, H HogenEsch, C Zurcher, A van den Hoven, P L Bruijnzeel
Chronic proliferative dermatitis (cpd) is a spontaneous mutation in C57BL/Ka mice (cpdm/cpdm). The dermatitis is characterized by redness, hairloss, scaling, pruritus and histologically by epithelial hyperproliferation, infiltration of eosinophils, macrophages and mast cells. Lesions similar to those in the skin occur in the esophagus and forestomach. In this paper, we describe the effect of drug treatments directed against epidermal hyperproliferation (calcipotriene and etretinate), against inflammation (corticosteroids and dapsone) and against pruritus (loratidine and capsaicin)...
October 2000: Experimental Dermatology
https://www.readbyqxmd.com/read/10425919/uncv-uncovered-a-new-mutation-causing-hairloss-on-mouse-chromosome-11
#9
S R Li, D P Wang, X L Yu, B S Ge, C E Wang, Y F Lu, J Q Li, N Wu, R F Li, S E Zhu, Z C Zhang, Y F Chen
A pair of mutant mice with a first sparse coat appeared spontaneously in the production stock of BALB/c mice with a normal coat. After being sib-mated, they produced three phenotypes in their progeny: mice with normal hair, mice with a first sparse coat and then a fuzzy coat, and uncovered mice. Genetic studies revealed the mutants had inherited an autosomal monogene that was semi-dominant. By using 11 biochemical loci--Idh, Car2, Mup1, Pgm1, Hbb, Es1, Es10, Gdc, Ce2, Mod1 and Es3--as genetic markers, two-point linkage tests were made...
June 1999: Genetical Research
https://www.readbyqxmd.com/read/9887492/-carboplatin-monotherapy-in-clinical-stage-i-of-seminoma-an-acceptable-alternative
#10
G Nöst, H Lipsky, E Würnschimmel
Between 1/1990-8/1997 two courses of single agent Carboplatin had been given to 36 patients with clinical stage I seminoma. Within an median follow up period of 52 months (17-88) 29 out of 34 patients were analyzed retrospectively. During this period no recurrences had been noted and nobody of our patients died (0% relapsrate, 100% survival-rate). The Carboplatin-therapy was well tolerated. Myelosuppression after chemotherapy was mild (WHO grade I). The experienced acute toxic side effects (max. grade II WHO) during and after chemotherapy had been nausea (37%), vomiting (14%) and mild hairloss (11%)...
November 1998: Der Urologe. Ausg. A
https://www.readbyqxmd.com/read/8574162/successful-treatment-of-accelerated-and-blastic-phase-of-chronic-myeloid-leukemia-with-high-dose-interferon-alpha-and-hydroxyurea-a-novel-approach
#11
U Jehn, C Pötscher, V Heinemann
Six patients with either acceleration or blast crisis of transformed chronic myeloid leukemia (CML) were treated with high-dose interferon alpha in combination with hydroxyurea. All patients responded to the treatment by reversal to stable chronic phase. Two of these patients responded repeatedly during their course of disease. Median time for return to chronic phase was 4 weeks. Adverse side-effects such as nausea, vomiting, hairloss, fever, prolonged cytopenia were not observed.
September 1995: Leukemia & Lymphoma
https://www.readbyqxmd.com/read/8273365/-interferon-therapy-in-essential-thrombocythemia
#12
H L Seewann
Interferon-alpha (IFN-alpha) exhibits a clear platelet reductive effect in patients with essential thrombocythemia as well as in other chronic myeloproliferative disorders with thrombocytosis. In a total of 51 patients with chronic myeloproliferative disorders with thrombocytosis we analyzed the effect of IFN-alpha in respect to platelet reduction, remission rates, induction- and maintenance dosage, long term tolerance and side effects. According to our classification CML 6, chronic mega-karyocytic granulocytic myelosis 5, essential thrombocythemia 26 and polycythemia vera 15 patients were treated...
1993: Wiener Medizinische Wochenschrift
https://www.readbyqxmd.com/read/7844949/-prenatal-eyelid-development-in-the-hl-mouse-a-hairless-mutant-of-the-colored-wild-mouse
#13
M Tost, S Kraus
BACKGROUND: A decisive condition for the clarification of malformations and degenerations is knowledge of the pre- and postnatal development. Therefore investigations were undertaken to determine the plan and lay-out of the eye-lids in an hairloss mutant of mouse. MATERIALS AND METHODS: Biomicroscopical and histological investigations were carried out in 51 hl-mice from the 10th day of gestation unto the birth. This particular mouse is a spontaneous hairloss mutant, in which corneal degenerations also occur...
November 1994: Klinische Monatsblätter Für Augenheilkunde
https://www.readbyqxmd.com/read/6882007/-phase-ii-study-of-vindesine-in-patients-with-primary-bronchogenic-carcinoma-by-cooperative-study-group
#14
(no author information available yet)
A phase II study of vindesine was performed by National Chest Hospital Lung Cancer Cooperative Study Group involving 21 institutions. Of 91 patients who entered into the study, 68 patients were evaluable. Response rates were 11.8% (3/33), 8.3% (1/12) and 14.3% (1/7) for small cell, adeno, squamous cell, and large cell carcinoma of the lung, respectively. Vindesine was given by bolus i.v. injection at doses of 3 to 5 mg weekly, and the total doses ranged from 12 to 24 mg with 8 responders. Adverse reactions of vindesine were leukopenia (less than 3000 cells/cmm, 54%), anorexia, peripheral neuropathies, hairloss, etc...
August 1983: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://www.readbyqxmd.com/read/5179930/-baldness-and-hairloss
#15
J W Mali
No abstract text is available yet for this article.
October 1, 1966: Tijdschrift Voor Ziekenverpleging
https://www.readbyqxmd.com/read/3868378/analysis-of-cataract-and-keratotic-damage-induced-by-4-diethylaminoethoxy-alpha-ethyl-benzhydrol-rgh-6201-in-rats
#16
Z Bencz, E Iván, E Cholnoky
RGH-6201 (4-diethylaminoethoxy-alpha-ethyl-benzhydrol) in the first dose-range finding study on rats produced severe, irreversible ophthalmic damage. The underlying mechanism was studied in a series of experiments with daily doses of 50, 100 and 200 mg/kg in rats by gavage. Lenticular damage appeared as a moderate nuclear degeneration during Week 4 of treatment with 50 mg/kg RGH-6201. This could be detected in the isolated eye and in histological examination but not by ophthalmoscopy. Keratitis and iridocyclitis developed about the 2nd week of treatment followed by epithelial proliferation in the lens under the anterior capsule in the higher dose groups...
1985: Archives of Toxicology. Supplement., Archiv Für Toxikologie. Supplement
https://www.readbyqxmd.com/read/1832134/hormone-studies-in-females-with-androgenic-hairloss
#17
J B Schmidt, A Lindmaier, A Trenz, B Schurz, J Spona
Reports on hormone analysis in androgenic hairloss in the female show partly contradicting results. Elevated as well as normal-range androgen levels have been found. The present study aimed at the investigation of a possibly more differentiated hormonal constellation by hormone analysis and additional determination of the hypophyseal level by the thyrotropin-releasing hormone (TRH) test. In 46 female patients with androgenic hairloss blood sampling for hormone analysis was performed. Determination of the androgens testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate (DHEAS), 17-hydroxy-progesterone acetate (17-OHP) and free testosterone (FT), of sex-hormone-binding globulin (SHBG), estradiol (E2), cortisol (F) and the hypophyseal luteinizing hormone (LH) and follicle-stimulating hormone (FSH) was performed by standard radioimmunoassay methods...
1991: Gynecologic and Obstetric Investigation
https://www.readbyqxmd.com/read/479550/repeated-epilation-a-genetic-epidermal-syndrome-in-mice
#18
J L Guenet, B Salzgeber, M T Tassin
Repeated epilation is an autosomal semidominant mutation located on chromosome 4 of the house mouse. Heterozygotes for Er show irregular hairloss. Homozygotes die immediately after birth from acute respiratory distress and exhibit an hypoplastic epidermal syndrome associated with morphological modifications of the oral cavity and of the limbs.
March 1979: Journal of Heredity
https://www.readbyqxmd.com/read/366488/-clinical-and-therapeutic-study-phase-ii-using-vp-16-213-and-methyl-ccnu-in-patients-with-inoperable-recurring-or-metastasizing-carcinomas-of-the-gastriointestinal-tract
#19
D Hartmann, J P Obrecht, G A Stalder
We carried out a phase-II-study in patients with tumors of the gastrointestinal tract, in order to test the effectiveness of the combination of VP-16/213 and ME-CCNU. We studied 15 patients (3 carcinomas of the stomach, 12 colon carcinomas) in a mostly advanced state of illness (disseminated, n = 13). One patient with gastric cancer attained a partial remission with a duration of remission of 9.1 months and a survival time of 14.1 months; the other two patients with cancer of the stomach were non-responders...
October 1978: Onkologie
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"